Genesco Inc. secured endorsements from all three major proxy advisory firms—ISS, Glass Lewis, and Egan-Jones—ahead of its annual meeting, effectively ending activist Bradley Radoff's campaign to reshape the footwear retailer's board. The trifecta arrived within 72 hours of each other, a coordination that typically signals institutional shareholders have already made their decision.
ISS, which influences roughly 25% of institutional votes, recommended shareholders support all nine incumbent directors. Glass Lewis and Egan-Jones followed with identical guidance. Radoff, who disclosed a 6.8% stake in Genesco in December, had nominated two candidates and pushed for operational changes at the $1.1 billion market-cap retailer, arguing the company's digital transformation lagged peers and that comparable-store sales growth had stalled. Genesco operates 1,425 stores across Journeys, Schuh, and Johnston & Murphy banners.
The advisory consensus matters because proxy fights at sub-$2 billion market-cap companies rarely survive a clean sweep. ISS and Glass Lewis together influence voting decisions at funds managing over $40 trillion in assets. When both firms align against an activist, the campaign loses access to the passive capital that determines tight votes. Radoff's filing disclosed he held 1.2 million shares purchased between $28 and $34; Genesco closed Tuesday at $31.47, down 18% year-to-date.
Genesco's defense centered on operational metrics that suggested stabilization rather than crisis. The company reported Q3 fiscal 2025 comparable sales up 2%, gross margin expansion of 90 basis points, and digital penetration reaching 21% of total revenue. Management highlighted $42 million in share repurchases over the trailing twelve months and pointed to a board refresh completed in 2023 that added retail and digital expertise. The proxy materials noted that five of nine directors joined within the past four years, undercutting Radoff's entrenchment argument.
The endorsement gives Genesco's board latitude to continue its current strategy without the distraction of a contested vote. The annual meeting is scheduled for June 19, 2025. Radoff has not yet filed a withdrawal notice, but activist campaigns at this market cap typically dissolve within 10 business days of losing all three advisory firms. Institutional shareholders who relied on the proxy guidance have already submitted preliminary votes; changing course would require affirmative board action, which rarely occurs.
The tells are in the timing. ISS released its report May 13, Glass Lewis May 14, Egan-Jones May 15—a cadence that suggests the firms coordinated their review cycles to avoid sending mixed signals. Genesco's stock moved 1.2% on the ISS news, then flattened, indicating the market had priced in a board victory. Radoff's silence since the Glass Lewis report suggests his legal counsel has advised against escalating a campaign with no institutional backing. The annual meeting will proceed, but the contested election effectively ended May 15 at 4:00 PM Eastern.